Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Gastrointestinal Stromal Tumor (GIST) × infigratinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Renal Pelvis and Ureter Urothelial Carcinoma 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Advanced Gastrointestinal Stromal Tumor (GIST) 1

Interventions

infigratinib 1 Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02257541 2020-03-30

BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed

16 enrolled 14 charts

GastrointestinalSarcoma

Advanced Gastrointestinal Stromal Tumor (GIST)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡